MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Revue Neurologique
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

123 results · 1 filter active ·
Results by year
20042025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
123 works in the cohort · of 4,299,418page 3 of 3

Labels cover 0 of 123 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 123 of 123 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Données de vie réelle relatives à l’utilisation d’Éculizumab dans la prise en charge des maladies du spectre de la neuromyélite optique (NMOSD) en France : modalités d’utilisation, efficacité et tolérance (ECUP4)
de Sèze, Caroline Papeix, David Laplaud, Emmanuelle Leray, Mickaël Piotaix, Ekbel Amri +3 more
2025· article· fr· Revue Neurologique· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrowconsensus · none
0
citations
affno abstractunlabeled
Résultats cliniques et d’imagerie par résonance magnétique de l’évobrutinib (EVO), un inhibiteur de la tyrosine kinase de Bruton (BTKi), dans le traitement de la sclérose en plaques récurrente (SEP-R) sur une période de 2,5 ans dans l’extension en ouvert
Patrick Vermersch, Douglas L. Arnold, Jerry S. Wolinsky, Eva Kubala Hardova, Anastasiia Kinkolykh, Davorka Tomic +1 more
2023· article· fr· Revue Neurologique· Medicine
distilled prediction:candidate · metaresearch+metaepi_narrow+research_integrityconsensus · research_integrity
0
citations
affno abstractunlabeled
O3-4 La mémoire décontextualisée chez les patients amnestic MCI
Emmanuel J. Barbeau, Mira Didic, Lejla Koric, Olivier Félician, Eve Tramoni, Eric Guedj +4 more
2009· article· fr· Revue Neurologique· Arts and Humanities
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · none
0
citations
affno abstractunlabeled
SCA27B/FGF14 : une ataxie peut en cacher une autre
Jean‐Loup Méreaux, Claire-Sophie Davoine, David Pellerin, Giulia Coarelli, Mathilde Renaud, Alexis Brice +1 more
2024· article· fr· Revue Neurologique· Medicine
distilled prediction:candidate · metaepi_narrow+research_integrity+insufficient_payloadconsensus · research_integrity+insufficient_payload
0
citations
affno abstractunlabeled
Efficacité à long terme du satralizumab dans les troubles du spectre de la neuromyélite optique (NMOSD) positifs aux anticorps anti-aquaporine-4 : résultats actualisés de l’étude en ouvert SakuraMoon
de Sèze, Jacqueline Palace, Anthony Traboulsee, Albert Saiz, Jeffrey L. Bennett, Ivana Vodopivec +1 more
2024· article· fr· Revue Neurologique· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · none
0
citations
affno abstractunlabeled
Données IRM, efficacité et sécurité d’emploi du tolébrutinib chez des patients atteints d’une SEP très active : données à 2 ans de l’étude de sécurité d’emploi à long terme de phase 2b (LTS, Long-Term Safety)
Robert J. Fox, Jiwon Oh, Douglas L. Arnold, Timothy J. Turner, Anthony Traboulsee, Daniel S. Reich
2023· article· fr· Revue Neurologique· Medicine
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · metaepi_narrow+research_integrity
0
citations
affno abstractunlabeled
Imagerie vasculaire en 2007
X. Leclerc, Jean‐Yves Gauvrit, D. Trystram, Catherine Oppenheim, J.-F. Méder, Jean‐Pierre Pruvo
2007· article· fr· Revue Neurologique· Medicine
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · insufficient_payload
0
citations

How this was built: Screen · Findings · About